NEPHRITOGENIC EPITOPES IN GOODPASTURES SYNDROME
Goodpastures 综合征中的肾源性表位
基本信息
- 批准号:6178040
- 负责人:
- 金额:$ 20.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-15 至 2002-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Description (Adapted from Investigator's Abstract): Glomerulonephritis in man is a major cause of morbidity, mortality and end stage renal disease (ESRD) leading to dialysis or transplantation. Autoimmune disease causes most forms of glomerulonephritis. Multiple pathogenic factors are involved in the final expression of glomerulonephritis including the deposition of antibodies and cell mediated immunity. Numerous models have been extensively studied to clarify pathogenic mechanisms, but most likely are induced by methods not directly relevant to man. This investigator has developed a model to examine the pathogenesis of Goodpasture's syndrome, a disease associated with antibody to the glomerular basement membrane, progressive crescentic glomerulonephritis and pulmonary hemorrhage. His studies suggest that a variety of antibodies develop after immunization with the responsible antigen, and that only a subset of these antibodies actually cause disease. Post-translational modification may be critical for expression of the pathogenic antigen. The PI hypothesizes that post-transcriptional modification of the amino acids constituting the immunizing antigen influences its ability to cause nephritis. The specific aims are to utilize biochemical and molecular methods to 1) identify the antigens which induce the glomerulonephritis, 2) determine if post-translational modification of the amino acids are present and what these modifications might be, and 3) examine the effect of alternation of these modifications on disease induction and course. Strong evidence indicates that the antigen which causes glomerulonephritis in this model is the same antigen or is located on the same protein that causes Goodpasture's syndrome in man. This model provides an opportunity for further study of pathogenic events in autoimmune glomerulonephritis and permits investigations of pathogenesis that cannot be accomplished in vitro. Information derived from this model will provide a better understanding of Goodpasture's syndrome and other types of autoimmune glomerulonephritis. Further, the knowledge resultant from these investigations may provide a basis for the eventual development of specific therapeutic interventions for Goodpasture's syndrome.
描述(改编自研究者摘要):人类肾小球肾炎是导致透析或移植的发病率、死亡率和终末期肾病(ESRD)的主要原因。自身免疫性疾病导致大多数形式的肾小球肾炎。多种致病因素参与了肾小球肾炎的最终表现,包括抗体沉积和细胞免疫。许多模型已被广泛研究,以澄清致病机制,但最有可能是诱导的方法不直接相关的man.This调查员开发了一个模型,以检查肺出血肾炎综合征的发病机制,一种疾病与抗体的肾小球基底膜,进行性新月体肾小球肾炎和肺出血。他的研究表明,在用相应的抗原免疫后,会产生各种抗体,而这些抗体中只有一部分会真正引起疾病。翻译后修饰对于致病性抗原的表达可能是关键的。PI假设构成免疫抗原的氨基酸的转录后修饰影响其引起肾炎的能力。具体目的是利用生物化学和分子方法1)鉴定诱导肾小球肾炎的抗原,2)确定是否存在氨基酸的翻译后修饰以及这些修饰可能是什么,3)检查这些修饰的交替对疾病诱导和病程的影响。强有力的证据表明,在这个模型中引起肾小球肾炎的抗原是相同的抗原或位于相同的蛋白质,导致Goodpasture综合征在man.This模型提供了一个机会,为进一步研究自身免疫性肾小球肾炎的致病事件,并允许调查的发病机制,不能在体外完成。从这个模型中获得的信息将提供更好地了解肺出血肾炎综合征和其他类型的自身免疫性肾小球肾炎。此外,从这些调查中获得的知识可能为最终开发Goodpasture综合征的具体治疗干预措施提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warren Kline BOLTON其他文献
Warren Kline BOLTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warren Kline BOLTON', 18)}}的其他基金
GROWTH HORMONE SECRETAGOGUE MK-677 THERAPY EFFECT ON IGF-1 LEVELS IN CKD & ESRD
生长激素分泌剂 MK-677 对 CKD 中 IGF-1 水平的治疗效果
- 批准号:
7951486 - 财政年份:2009
- 资助金额:
$ 20.11万 - 项目类别:
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control
实验性自身免疫性肾炎:发病机制和控制中的表位扩散
- 批准号:
7565911 - 财政年份:2008
- 资助金额:
$ 20.11万 - 项目类别:
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control
实验性自身免疫性肾炎:发病机制和控制中的表位扩散
- 批准号:
8033245 - 财政年份:2008
- 资助金额:
$ 20.11万 - 项目类别:
GROWTH HORMONE SECRETAGOGUE MK-677 THERAPY EFFECT ON IGF-1 LEVELS IN CKD & ESRD
生长激素分泌剂 MK-677 对 CKD 中 IGF-1 水平的治疗效果
- 批准号:
7718581 - 财政年份:2008
- 资助金额:
$ 20.11万 - 项目类别:
Growth hormone secretagogue MK-677 therapy in CKD and ESRD
生长激素促泌剂 MK-677 治疗 CKD 和 ESRD
- 批准号:
7454236 - 财政年份:2007
- 资助金额:
$ 20.11万 - 项目类别:
Growth hormone secretagogue MK-677 therapy in CKD and ESRD
生长激素促泌剂 MK-677 治疗 CKD 和 ESRD
- 批准号:
7305316 - 财政年份:2007
- 资助金额:
$ 20.11万 - 项目类别:
ASSESSMENT OF GHRELIN LEVELS IN CHRONIC KIDNEY DISEASE
慢性肾脏病中生长素释放肽水平的评估
- 批准号:
7205484 - 财政年份:2005
- 资助金额:
$ 20.11万 - 项目类别:
Assessment Of Ghrelin Levels In Chronic Kidney Disease
慢性肾脏病中生长素释放肽水平的评估
- 批准号:
7043015 - 财政年份:2004
- 资助金额:
$ 20.11万 - 项目类别:
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS
盐酸多奈哌齐(ARICEPT)药代动力学
- 批准号:
6579051 - 财政年份:2002
- 资助金额:
$ 20.11万 - 项目类别:
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS
盐酸多奈哌齐(ARICEPT)药代动力学
- 批准号:
6477578 - 财政年份:2001
- 资助金额:
$ 20.11万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 20.11万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 20.11万 - 项目类别: